Pay in 4 interest-free payments of $5.86 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Serious suppliers document 99 % with a chromatogram
Every batch is prepared under strict quality standards to ensure reliability and reproducibility in laboratory work, with a batch-specific Certificate of Analysis included
Off-label clinical use is expanding into specialized centers, with Palatin Technologies also launching a Phase 2 study of bremelanotide co-administered with a PDE5 inhibitor for ED patients who dont respond to PDE5i monotherapy with Phase 3 advancement planned for 2025
Wang et al., 2025b
Andreeff, M, Hansen H, Cirrincione C, Filippa D, Thaler H
US$ 24.94
US$ 24.76
US$ 27.35
